β-Cyclodextrin inclusion complex to improve physicochemical properties of pipemidic acid: characterization and bioactivity evaluation.

scientific article published on 25 June 2013

β-Cyclodextrin inclusion complex to improve physicochemical properties of pipemidic acid: characterization and bioactivity evaluation. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3390/IJMS140713022
P932PMC publication ID3742172
P698PubMed publication ID23799358
P5875ResearchGate publication ID242015380

P50authorGaetano MalgieriQ57599970
Carla IserniaQ57639099
Rosa IacovinoQ60608174
Margherita LavorgnaQ44643500
Marina IsidoriQ44643515
P2093author name stringChiara Russo
Luigi Russo
Agostino Russo
Filomena Rapuano
Jolanda Valentina Caso
P2860cites workOptimal methods for evaluating antimicrobial activities from plant extracts.Q54375369
[The use of pipemidic acid in urinary infections]Q70581151
Determination of binding stoichiometry by the continuous variation method: the Job plotQ70610458
The Stability of Cyclodextrin Complexes in SolutionQ77651433
Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranesQ84728460
The program XEASY for computer-supported NMR spectral analysis of biological macromoleculesQ27860993
Pharmaceutical composition of hydrochlorothiazide:β-cyclo-dextrin: preparation by three different methods, physico-chemical characterization and in vivo diuretic activity evaluation.Q33915479
Pipemidic Acid: Its Activities Against Various Experimental InfectionsQ34972061
Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteriaQ35757560
Physicochemical characterization and cytotoxic activity evaluation of hydroxymethylferrocene:β-cyclodextrin inclusion complex.Q39344693
Selective cytotoxicity of goniothalamin against hepatoblastoma HepG2 cells.Q39562856
Inhibition of Micrococcus luteus DNA gyrase by norfloxacin and 10 other quinolone carboxylic acidsQ39851068
Comparative activities of AM-715 and pipemidic and nalidixic acids against experimentally induced systemic and urinary tract infectionsQ39854448
Quinolone analogue inhibits tubulin polymerization and induces apoptosis via Cdk1-involved signaling pathwaysQ40138218
Pipemidic acid, a new antibacterial agent active against Pseudomonas aeruginosa: in vitro propertiesQ40944721
Experimental and clinical studies on fluoroquinolone-insusceptible Escherichia coli isolated from patients with urinary tract infections from 1994 to 2007.Q43247456
Synthesis, characterization, and antibacterial activities of some rare Earth metal complexes of pipemidic acidQ44433539
Solubility enhancement of celecoxib using beta-cyclodextrin inclusion complexes.Q44798336
Influence of solvent composition on the solid phase at equilibrium with saturated solutions of quinolones in different solvent mixturesQ44933529
CHM-1, a novel synthetic quinolone with potent and selective antimitotic antitumor activity against human hepatocellular carcinoma in vitro and in vivo.Q46748278
Ultra-fast FFT protein docking on graphics processorsQ48191415
Pyrido(2,3-d)pyrimidine antibacterial agents. 3. 8-Alkyl- and 8-vinyl-5,8-dihydro-5-oxo-2-(1-piperazinyl)pyrido(2,3-d)pyrimidine-6-carboxylic acids and their derivativesQ50229980
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue7
P407language of work or nameEnglishQ1860
P921main subjectpipemidic acidQ754986
P304page(s)13022-13041
P577publication date2013-06-25
P1433published inInternational Journal of Molecular SciencesQ3153277
P1476titleβ-Cyclodextrin inclusion complex to improve physicochemical properties of pipemidic acid: characterization and bioactivity evaluation
P478volume14

Reverse relations

cites work (P2860)
Q61813451A New Approach for Improving the Antibacterial and Tumor Cytotoxic Activities of Pipemidic Acid by Including It in Trimethyl-β-cyclodextrin
Q38289914Alpha- and Beta-Cyclodextrin Inclusion Complexes with 5-Fluorouracil: Characterization and Cytotoxic Activity Evaluation.
Q38634401Comparative In Vitro Controlled Release Studies on the Chronobiotic Hormone Melatonin from Cyclodextrins-Containing Matrices and Cyclodextrin: Melatonin Complexes.
Q40135091Design, Preparation and Evaluation of HPMC-Based PAA or SA Freeze-Dried Scaffolds for Vaginal Delivery of Fluconazole
Q89909729Effect of antioxidant activity of caffeic acid with cyclodextrins using ground mixture method
Q58062554Investigating the inclusion properties of aromatic amino acids complexing beta-cyclodextrins in model peptides
Q54959311Nanoparticles with high payloads of pipemidic acid, a poorly soluble crystalline drug: drug-initiated polymerization and self-assembly approach.
Q58904705Stimulatory Effects of Methyl-β-cyclodextrin on Spiramycin Production and Physical-Chemical Characterization of Nonhost@Guest Complexes
Q58691429Structural Characterization of the FlmC Protein Involved in Biofilm Formation
Q34358839Triethanolamine stabilization of methotrexate-β-cyclodextrin interactions in ternary complexes.
Q48214486Zinc Complexes of Cyclodextrin-bearing 8-Hydroxyquinoline Ligands: A Comparative Study.

Search more.